Clinical trial
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
NCT00078117 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00078117 |
|---|---|
| Title | Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 |
| Official title | Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules |
| Lead sponsor | University of California, Los Angeles, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Enrollment | 516 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Feb 20, 2004 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: